These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26199242)

  • 1. [Analysis of the Side Effects of Docetaxel with Cyclophosphamide (TC Therapy)].
    Imanishi S; Koyama H; Matsui C
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):709-11. PubMed ID: 26199242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and tolerance of docetaxel (especially 75 mg/m2) with cyclophosphamide (TC therapy) as adjuvant chemotherapy for Japanese patients with operable breast cancer].
    Watanabe K; Taguchi K; Yamamoto M; Jotoku H; Tamura M
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1265-9. PubMed ID: 20647707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety of docetaxel with cyclophosphamide (TC) therapy as adjuvant chemotherapy for Japanese women with operable breast cancer].
    Tashiro H; Sagawa T; Okada K; Kurokawa T; Soga H; Watanabe R; Yasuoka Y; Honda K; Watanabe Y; Gangi J; Akehi S; Masuda J; Nomoto M;
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):393-6. PubMed ID: 17353630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Feasibility of adjuvant docetaxel plus cyclophosphamide therapy for breast cancer].
    Naito K; Oura S; Yoshimasu T; Nakamura R; Hirai Y; Kiyoi M; Miyasaka M; Okamura Y
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1913-6. PubMed ID: 20948255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
    Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
    JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and tolerability of docetaxel with cyclophosphamide for early breast cancer].
    Kawabata H; Iwatani T; Makuuchi R; Miura D; Suzuki N; Nakazawa H
    Gan To Kagaku Ryoho; 2010 May; 37(5):835-9. PubMed ID: 20495312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Pegfilgrastim Primary Prophylactic Administration on Relative Dose Intensity(RDI)in Postoperative Adjuvant Chemotherapy(TC Therapy)for Breast Cancer - A Single-Center, Retrospective Study].
    Nagashima Y; Chijimatsu H; Furuya K; Kondo J; Maeda Y; Somura H; Takemoto N; Yahara N; Abe T; Hayashi H; Kubo H; Yamamoto S; Nagano H
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2087-2090. PubMed ID: 29361623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of prior administration of cyclophosphamide in TC combination treatment.
    Abe H; Kawai Y; Mori T; Cho H; Kubota Y; Umeda T; Tani T
    Breast Cancer; 2014 Mar; 21(2):202-7. PubMed ID: 22696251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients.
    Sanna G; Pestrin M; Zafarana E; Biagioni C; Cavaciocchi D; Turner N; Di Leo A; Biganzoli L
    Breast; 2013 Oct; 22(5):926-32. PubMed ID: 23707082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.
    Burkard ME; Wisinski KB; Njiaju UO; Donohue S; Hegeman R; Stella A; Mansky P; Shah V; Goggins T; Qamar R; Dietrich L; Kim K; Traynor AM; Tevaarwerk AJ
    Clin Breast Cancer; 2014 Jun; 14(3):205-11. PubMed ID: 24342730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer.
    Nakatsukasa K; Koyama H; Oouchi Y; Imanishi S; Mizuta N; Sakaguchi K; Fujita Y; Fujiwara I; Kotani T; Matsuda T; Fukuda K; Morita M; Kawakami S; Kadotani Y; Konishi E; Yanagisawa A; Taguchi T
    Breast Cancer; 2017 Jan; 24(1):63-68. PubMed ID: 26754092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer.
    Yu JL; Chan K; Kurin M; Pasetka M; Kiss A; Sridhar SS; Warner E
    Breast J; 2015; 21(6):658-64. PubMed ID: 26387577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.
    Basile FG; Creamer S
    J Clin Oncol; 2011 Dec; 29(34):e840-1. PubMed ID: 22025156
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
    Jones SE; Savin MA; Holmes FA; O'Shaughnessy JA; Blum JL; Vukelja S; McIntyre KJ; Pippen JE; Bordelon JH; Kirby R; Sandbach J; Hyman WJ; Khandelwal P; Negron AG; Richards DA; Anthony SP; Mennel RG; Boehm KA; Meyer WG; Asmar L
    J Clin Oncol; 2006 Dec; 24(34):5381-7. PubMed ID: 17135639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].
    Yamamoto N; Tabei T; Inoue K; Takei H; Sato N; Yanagita Y; Fujisawa T; Fujii H; Saeki T; Kurosumi M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):57-63. PubMed ID: 20087033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
    Wielgus KK; Berger AM; Hertzog M
    Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
    Oshiro C; Arai T; Kamigaki S; Matsuura M
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of toxicity by reversing the order of infusion of docetaxel and cyclophosphamide.
    Hanaoka M; Kawabata H; Iwatani T; Takano T; Miura D
    Chemotherapy; 2013; 59(2):93-8. PubMed ID: 24008436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant docetaxel for node-positive breast cancer.
    Ahluwalia MS; Daw HA
    N Engl J Med; 2005 Sep; 353(9):954-5; author reply 954-5. PubMed ID: 16135845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Feasibility of FEC 100 followed by DOC 100 as adjuvant chemotherapy for breast cancer].
    Abe H; Umeda T; Tanaka M; Kawai Y; Mori T; Cho H; Kubota Y; Mekata E; Kurumi Y; Tani T
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1483-7. PubMed ID: 20716872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.